Chemical modification of L-asparaginase from Escherichia coli with a modified polyethyleneglycol under substrate protection conditions

Biotechnology Letters

Volumn 26, Issue 9, 2004, Pages 753-756

  Zhang, Jian Feng ^a   Shi, Ling Yang ^a   Wei, Dong Zhi ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chemical modification; L asparaginase; Polyethyleneglycol

Indexed keywords

ASPARAGINASE; MACROGOL DERIVATIVE;

AFFINITY CHROMATOGRAPHY; ARTICLE; BIOTECHNOLOGY; CHEMISTRY; CHROMATOGRAPHY; DOSE RESPONSE; ENZYMOLOGY; ESCHERICHIA COLI; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME;

ASPARAGINASE; BIOTECHNOLOGY; CHROMATOGRAPHY; CHROMATOGRAPHY, AFFINITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; POLYETHYLENE GLYCOLS; TIME FACTORS;

ESCHERICHIA COLI;

EID: 3342973885     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BILE.0000024100.49716.3d     Document Type: Article

References (9)

1. Ashihara Y, Kono T, Yamazaki S, Inada Y (1978) Modification of E. coli L-asparaginase with polyethylene glycol: disappearance of binding ability to anti-asparaginase serum. Biochem. Biophys. Res. Commun. 83: 385-391.
2. Maita T, Morokuma K, Matsuda G (1974) Amino acid sequence of L-asparaginase from Escherichia coli. J. Biochem. 76: 1351-1354.
3. 2). Chem. Lett. 103: 773-776.
4. Matsuyama H, Taguchi R, Ikezawa H (1991) Phospholipase D modified with a polyethylene glycol derivative. Chem. Pharm. Bull. 39: 743-746.
5. Qian GQ, Ma JB, Zhou JY, He BL (1997) Chemical modification of E. coli L-asparaginase with poly(N-vinylpyrrolidone-co-maleic anhydride). React. Funct. Polym. 32: 117-121.
6. Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54: 459-476.
7. Soares AL, Guimarães GM, Polakiewicz B, Pitombo RNM et al. (2002) Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli L-asparaginase. Inter. J. Pharm. 237: 163-170.
8. Uren JR, Hargis BJ, Beardsley P (1982) Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase. Cancer Res. 42: 4068-4071.
9. Wileman T, Foster RL, Elliot PNC (1986) Soluble asparaginase-dextran conjugates show increased circulatory persistence and lowered antigen reactivity. J. Pharm. Pharmacol. 38: 264-271.